| |
|
|
| |
EVENT DETAILS |
<P CLASS="MsoNormal">Join Columbia WIN for a discussion exploring venture capital investing in biotech companies with Charlotte Hubbert of The Bill & Melinda Gates Foundation. Charlotte brings a wealth of experience in venture capital investing, startups, & emerging biotechnology, having previously served as Vice President with H.I.G. BioVentures & an associate at Accelerator Corporation, where she was involved in the strategic development & management of many companies including Oncofactor, Groove Bipharma, & Acylin Therapeutics.</P>
<P CLASS="MsoNormal">Following the presentation, there will be a networking reception with drinks & appetizers in the same location from 6 to 7 pm.</P>
<HR>
<P CLASS="MsoNormal"><A HREF="http://www.bloomberg.com/research/stocks/private/person.asp?personId=217656407&privcapId=4160895&previousCapId=22049&previousTitle=New%20Enterprise%20Associates" TARGET="_blank" REL="noopener noreferrer noopener nofollow noopener noreferrer nofollow nofollow noreferrer nofollow">Dr. Charlotte Hubbert</A>is a Partner with Gates Foundation Venture Capital, investing in innovative technologies that support The Bill & Melinda Gates Foundation initiatives in Global Health & Agriculture. Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics & medical devices at all stages of development. She was BOD observer at Cardeas Pharma & Alder Biopharmaceuticals. Charlotte started her career in early stage biotech investing at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing & managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development & management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori & Pharmselex. Charlotte currently serves as an observer on the board of directors of Synlogic, Sera Prognostics, Lodo Therapeutics & Vir Biotechnology.</P>
<P CLASS="MsoNormal"><SPAN></SPAN></P>
<P CLASS="MsoNormal"><SPAN>Charlotte earned a B.S. in Microbiology from the University of Washington & a Ph.D. in Pharmacology & Cancer Biology from Duke University. She did her post-doctoral work in stem cells & regenerative medicine at the Institute for Stem Cells & Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14).</SPAN></P>
|
|
|
|
|
|
